Will Medicare Cover GLP-1 Drugs for Seniors? What Florida Beneficiaries Need to Know

For years, Medicare has been legally prohibited from covering prescription drugs used purely for weight loss. That is about to change. The Centers for Medicare and Medicaid Services (CMS) has announced two overlapping programs that will give eligible Florida seniors access to GLP-1 medications like Wegovy and Zepbound at dramatically reduced cost, starting as early as July 2026.

Here is what Florida Medicare beneficiaries need to understand before calling their doctor.

What Are GLP-1 Medications?

GLP-1 agonists are a class of injectable and oral medications originally developed to treat type 2 diabetes. In higher doses, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have been shown to produce significant weight loss in clinical trials. For older adults managing obesity alongside conditions like heart failure, hypertension, or chronic kidney disease, these drugs can have meaningful health implications beyond the scale.

The problem has been cost. Without insurance coverage, a monthly supply of Wegovy can run well over $1,000 out of pocket, a price that places it out of reach for most people on a fixed income.

The Two Programs Florida Seniors Should Know About

CMS has created a two-part pathway to expand access. Both programs are distinct, with different timelines, mechanics, and eligibility rules.

1. The Medicare GLP-1 Bridge (July 1, 2026 -- December 31, 2027)

The Bridge is a federal demonstration program that operates outside the standard Part D benefit. That distinction matters: your Part D plan does not need to opt in. CMS has contracted with Humana as the central processor, which means that prior authorizations, claims, and pharmacy payments all run through Humana regardless of which Medicare plan you carry.

Eligible beneficiaries who qualify pay a flat $50 per month copay at the pharmacy. CMS covers the rest.

Drugs covered under the Bridge include Wegovy (injection and tablet forms), Zepbound (KwikPen formulation only), and Foundayo.

2. The BALANCE Model (Medicaid: May 2026 / Medicare Part D: January 2027)

BALANCE stands for Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth. It is a longer-term voluntary model in which CMS negotiated directly with manufacturers Eli Lilly and Novo Nordisk on pricing.

For Medicaid enrollees, the BALANCE Model is already launching in participating states as early as May 2026. For Medicare Part D, the BALANCE Model is structured to begin January 1, 2027, though CMS has confirmed that the 80% plan participation threshold required to trigger the full launch was not met, making the GLP-1 Bridge the primary Medicare access pathway through the end of 2027.

Who Qualifies for the GLP-1 Bridge?

Eligibility is clinical, not automatic. Your provider must submit a prior authorization request attesting that you meet one of the following criteria:

• BMI of 35 or higher at the time GLP-1 therapy was initiated
• BMI of 30 or higher plus one qualifying condition: heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or higher
• BMI of 27 or higher plus one qualifying condition: pre-diabetes, previous heart attack, or previous stroke

You must also be enrolled in a standalone Medicare Part D plan or a Medicare Advantage plan with prescription drug coverage (MA-PD). Special Needs Plans and employer group waiver plans are also eligible.

Dual-eligible beneficiaries, those who qualify for both Medicare and Medicaid, may have additional pathways through the BALANCE Medicaid launch.

What This Means for Older Adults Managing Multiple Conditions

The clinical criteria are worth examining closely because they map directly onto conditions that are common in the senior population. Chronic kidney disease, hypertension, and a history of cardiovascular events are not edge cases among Florida's older adults. They are among the most frequent diagnoses managed in assisted living facilities and nursing homes across the state.

For families currently comparing senior care options in Florida, a resident's eligibility for GLP-1 coverage under the Bridge is worth discussing with their prescribing physician, particularly for those managing obesity alongside one of the qualifying cardiovascular or metabolic conditions listed above.

If you are evaluating facilities for a family member, understanding what medications a facility can support, and whether their care staff is equipped to monitor patients on GLP-1 therapy, is a reasonable question to raise during a tour.

What the $50 Copay Actually Covers

The flat $50 monthly copay applies at the pharmacy counter. CMS has structured the Bridge so that Humana reimburses pharmacies directly at no less than the wholesale acquisition cost of the drug, minus the $50 copay, plus a dispensing fee. There is no deductible applied under the Bridge for these medications.

One important caveat: the prior authorization process requires your provider to submit to the Bridge's central processor through a specific billing code (BIN 028918 / PCN MEDDGLP1BR), not to your regular insurance company. Providers unfamiliar with the Bridge may need guidance. It may be worth printing the CMS overview and bringing it to your next appointment.

SHIP Can Help Florida Seniors Navigate This

Florida's State Health Insurance Assistance Program (SHIP) offers free, unbiased Medicare counseling to beneficiaries across the state. If you are uncertain whether you qualify for the Bridge or how it interacts with your current Part D plan, a SHIP counselor can walk you through your specific coverage.

Florida's SHIP program is administered through the Florida Department of Elder Affairs and operates through local Area Agencies on Aging across all 67 counties. There is no cost and no sales pitch involved.

What Families Comparing Care Options Should Know

If your family is currently researching Florida nursing homes or assisted living facilities for a parent or spouse, the GLP-1 Bridge and BALANCE Model are new variables worth understanding for any resident managing obesity-related conditions.

Our Florida senior care directory includes government inspection data, staffing levels, and violation histories for more than 3,700 licensed facilities across Florida. When evaluating facilities, you can compare nursing homes side by side using CMS data to assess quality indicators before making a decision.

For families navigating decisions about assisted living in Florida, understanding a facility's capacity to support residents on complex medication regimens, including newer GLP-1 therapies, is worth adding to your list of questions when touring.

You can also explore Florida's memory care options, where the intersection of obesity, metabolic disease, and cognitive decline makes medication management particularly consequential.

Key Dates to Track

• May 2026 -- BALANCE Model Medicaid coverage begins in participating states
• July 1, 2026 -- Medicare GLP-1 Bridge begins; eligible Part D beneficiaries can access Wegovy, Zepbound, or Foundayo for $50/month
• December 31, 2027 -- Medicare GLP-1 Bridge currently scheduled to end
• January 2027 -- BALANCE Model Medicare Part D launch (contingent on plan participation thresholds)

These dates and program details are subject to change. CMS continues to release updated guidance as the Bridge rolls out.

Bottom Line for Florida Seniors

This is a genuine shift in Medicare's approach to obesity treatment, and it comes with real access at a price point most seniors can manage. The $50 copay, broad Part D plan eligibility, and no requirement for your specific plan to opt in make the Bridge more accessible than most new federal programs at launch.

The key steps: confirm your Part D enrollment, talk to your doctor about whether you meet the clinical criteria, and ask them to submit the prior authorization through the Bridge's central processor when the program opens July 1.

If you have questions about Florida senior care options while navigating this alongside a placement decision, our Florida eldercare directory is free to use and requires no account or sign-up.

---

Sources: CMS.gov Medicare GLP-1 Bridge program page; KFF BALANCE Model brief, May 2026; CMS Innovation Center press release, December 2025.